Introduction {#S5}
============

Small for gestational age (SGA) occurs more commonly among very preterm newborns than among their peers born closer to term ([@R1]). SGA preterm infants are more likely than their more appropriately grown peers to have structural abnormalities of the brain ([@R2]). They are also more likely to have multiple expressions of developmental delay/limitations, including low scores on cognition assessments ([@R3], [@R4]). These abnormalities are compatible with early direct insults to the brain or disturbances to developmental processes.

Systemic inflammation also places preterm infants at increased risk of functional limitations and indicators of reduced brain volume ([@R5]--[@R13]).

In a two-hit model of brain damage, SGA appeared to sensitize neonatal rats to a subsequent inflammatory stimulus, resulting in more brain damage than seen in control rats following the same inflammatory stimulus ([@R14]). We are not aware of any report of an assessment of such a two-hit model in extremely low gestational age human newborns. Such an assessment might help elucidate how much of the brain damage in SGA preterm newborns can be attributed to growth-restriction, and how much to subsequent inflammation.

Results {#S6}
=======

Sample description {#S7}
------------------

Of the 805 infants born before the 28^th^ week of gestation who had inflammation-related proteins measured on two days in perinatal blood spots, a Bayley Scales of Infant Development assessment at age 2 years and a Gross Motor Function Classification System score \< 1 at 2 years, 11% (N=91) had an MDI \< 55, which is approximately 85-fold the expected 0.13% for a score more than 3 standard deviations below the expected mean ([Table 1](#T1){ref-type="table"}). Another 85 children had an MDI in the 55--69 range, which places their MDI more than 2 standard deviations below the expected mean, but above the 3 standard deviations criterion. The sample consists of these 176 children plus their 629 peers with higher MDI scores who also were able to walk and had proteins measured in perinatal blood spots.

Potential confounders: delivery and placenta characteristics {#S8}
------------------------------------------------------------

We sought characteristics and exposures that might distort an assessment of the relationships between each of the antecedents of interest (*i.e.*, SGA and postnatal systemic inflammation) and the outcomes of interest, an MDI \< 55 and an MDI between 55 and 69, in light of the contribution of the other antecedents. Women who had severe preeclampsia were more likely than others to give birth to an SGA infant (55% vs 8% for pre-labor rupture of membranes and 7% for preterm labor) and to infants with a very low MDI (17% vs 14% for pre-labor rupture of membranes and 9% for preterm labor) ([Table 2](#T2){ref-type="table"}). Infants born to these women were not at increased risk of having persistent or recurring elevated blood concentrations of inflammation-related proteins. Delivery for a fetal indication was also associated with both an MDI in the 55--69 range and persistent/recurrent elevated concentrations of IL-1beta, IL-8, and ICAM-1. Receipt of magnesium for seizure prophylaxis (a correlate of preeclampsia) was associated with both SGA and an MDI \< 55, but not with elevated concentrations of inflammation-associated proteins. Infants whose placenta harbored an organism or had histologic inflammation of the membranes or umbilical cord were less likely than others to have been SGA, but were not at increased risk of an MDI \<55. Those whose placenta and umbilical cord had histologic inflammation were more likely than others to have elevated concentrations of inflammation-related proteins.

Potential confounders: characteristics of the newborn {#S9}
-----------------------------------------------------

Boys were less likely than girls to be SGA (10% vs 19%) and more likely to have an MDI \< 55 and an MDI between 55 and 69 ([Table 3](#T3){ref-type="table"}). The lower the gestational age, the higher the rate of very low MDI. SGA infants were more likely than others to have had elevated concentrations of IL-6, TNF-alpha, IL-8, and ICAM-1 on two separate days during the first two weeks following birth. The smaller the head circumference at birth, the higher the rate of very low MDI, and of elevated blood concentrations of inflammation-related proteins on two separate days.

Potential confounders: postnatal characteristics {#S10}
------------------------------------------------

Infants who had hyperoxemia, hypercarbia, and acidemia on two of the first three postnatal days were more likely than others to be SGA, but not appreciably more likely to have a very low MDI, although newborns with hypercarbia or acidemia were at increased risk of an MDI in the 55--69 range ([Table 4](#T4){ref-type="table"}). Newborns who had early postnatal acidemia were more likely than others to be SGA, and have prominent systemic inflammation. Bacteremia was associated with both an MDI \<55 and with systemic inflammation, but not with SGA. Infants who were ventilated on days 7, 14 and 21 were more likely than others to have SGA, low MDIs, and systemic inflammation. MDI in the 55--69 range was minimally associated with both late bacteremia and ventilation.

Influence of the co-occurrence of SGA and inflammatory stimuli on low MDI {#S11}
-------------------------------------------------------------------------

The risk of an MDI \< 55 was highest in SGA infants who had bacteremia during the second, third, or fourth weeks, while the risk of an MDI between 55 and 69 was elevated among SGA infants who had bacteremia during the first postnatal week ([Table 5](#T5){ref-type="table"}). The risk of an MDI \< 55 was also elevated in SGA infants who were ventilated on postnatal day 7 or after. In contrast, however, ventilation did not appear to have a disproportionate effect on SGA infants.

Odds ratios of a very low or moderately low MDI among children classified by whether or not they were SGA and by protein concentration elevations {#S12}
-------------------------------------------------------------------------------------------------------------------------------------------------

Because we constructed a separate model for each protein, [Table 6](#T6){ref-type="table"} displays the results obtained with 25 separate models.

MDI \< 55 {#S13}
---------

Compared to children who had neither SGA, nor an elevated concentration of the individual protein on two separate days separated by approximately one week (fourth data column), those with SGA, but without repeatedly high concentrations of an individual protein, had a risk of an MDI \< 55 in the range of 1.7 to 3.8, with most odds ratios significant at p \<.01 (third data column) ([Table 6](#T6){ref-type="table"}). In essence, these infants were at increased risk, regardless of the protein assessed. Their increased risk is associated with SGA and not with systemic inflammation. The odds ratios vary for different proteins because the risk of a very low MDI associated with SGA in these models is influenced by the effect of elevated protein concentrations on the risk among other infants. In contrast, those SGA babies who had repeatedly high concentrations of SAA, IL-1β, IL-6, TNF-α, IL-8, MIP-1β, ICAM-1, E-SEL, and/or IGFBP-1 were at much higher risk of a very low MDI (first data column). Most of the odds ratios for these children were double those of their SGA peers who did not have repeatedly elevated concentrations of these proteins (third data column). The risks of a very low MDI were significantly increased in infants who did not have SGA, but did have recurrent/persistent elevated concentrations of CRP, SAA, IL-8, ICAM-1, E-SEL, and VEGF-R2 (second data column). These odd ratios were not as high as those seen in among SGA infants who had systemic inflammation.

In separate analyses (not shown), only bacteremia, and not the indication for delivery or duration of ventilation contributed to the risk of an MDI \<55, without appreciably reducing the risks associated with SGA and indicators of systemic inflammation. The odds ratios for bacteremia were close to 2.0 and were statistically significant at p \< .01. No interaction was seen between SGA and either bacteremia, delivery indication, or duration of ventilation.

MDI = 55--69 {#S14}
------------

SGA infants who did not have repeatedly high concentrations of an individual protein, were not at appreciably increased risk of an MDI in the 55 to 69 range (next to last data column). Among SGA infants who had repeatedly high concentrations of individual proteins, SAA was the only protein to achieve statistical significance (third data column from the right). Although repeatedly high concentrations of several proteins were associated with increased risk of an MDI in the 55--69 range among SGA infants, only MIP-1beta had a statistically significantly elevated odds ratio (fourth data column from the right).

Discussion {#S15}
==========

Our main findings are that extremely preterm SGA newborns were at increased risk of a very low MDI (\<55). When they had systemic inflammation in addition to SGA, their risks were considerably higher than the risks associated with systemic inflammation in infants who were not SGA at birth or infants without inflammation or SGA. In essence, SGA alone, or phenomena associated with SGA, appear to place SGA newborns at increased risk, and this risk is prominently heightened if they were also exposed to prolonged or repetitive systemic inflammation during the first two weeks after birth.

Limitations and strengths {#S16}
-------------------------

The weaknesses of our study are those of all observational studies. We are unable to distinguish between causation and association as explanations for what we found.

Our study has several strengths. First, we selected infants based on gestational age, not birth weight, in order to minimize confounding due to factors related to fetal growth restriction ([@R15]). Second, we collected all of our data prospectively. Third, examiners were not aware of the medical histories of the children they examined, thereby minimizing "diagnostic suspicion bias" ([@R16]). Fourth, we have minimized observer variability as best we can in the assessments of neurodevelopmental functions ([@R17]). Fifth, attrition in the first two years was modest. Sixth, our protein data are of high quality ([@R18]), and have high content validity ([@R19]--[@R22]).

Maternal and fetal indications for delivery, SGA, and inflammation {#S17}
------------------------------------------------------------------

Although preeclampsia might not be an inflammatory disorder primarily, many characteristics and associations link it to inflammatory phenomena ([@R23]). Thus, the first hit might have been exposure to maternal inflammation ([@R24]).

SGA infants tended to have higher blood concentrations of IL-6, TNF-alpha, IL-8, and ICAM-1 on repeated occasions than others. Nevertheless, although 55% of infants born to preeclamptic women were SGA, they were not more likely than others to have repeated elevations of blood concentrations of inflammation-associated proteins. In contrast, infants delivered for fetal indications tended to have prominently elevated concentrations of IL-1beta, IL-8, and ICAM-1, even though only 38% of these newborns were SGA. Perhaps the magnesium given to preeclamptic women dampened the inflammatory responses of their SGA newborns ([@R25]).

SGA, postnatal systemic inflammation, and very low MDI {#S18}
------------------------------------------------------

The odds ratios of an MDI \< 55 associated with persistent/recurrent elevated concentrations of SAA, IL-1beta, IL-6, TNF-alpha, IL-8, ICAM-1, E-Selectin, and IGFBP-1 were considerably higher among SGA children than among their peers. These observations are compatible with two possibilities. One is that processes associated with SGA, and processes associated with systemic inflammation each contribute independently to risk of a very low MDI. The other is that processes associated with SGA sensitize the brain to the adverse effects of postnatal inflammation.

Two-hit models of brain damage {#S19}
------------------------------

"Morbidities associated with preterm delivery appear to be additive to those associated with fetal growth restriction so SGA, preterm infants may be at great risk for poor neurodevelopmental outcome" ([@R26]). This quote exemplifies the concept of the greater the number of risk factors, the higher the risk. On the other hand, the heightened risk might not be additive.

This two-hit model is exemplified by the greater extent of brain damage following intracerebral lipopolysaccharide (endotoxin) among growth-restricted rats than among rats that were not growth-restricted ([@R14]). In this model, one hit (the inflammatory stimulus, lipopolysaccharide) is followed by damage, but a previous hit (a process associated with SGA, or perhaps multiple processes), allows the second hit to result in greater damage than if the first hit had not occurred. No abnormalities were seen in the brains of the growth-restricted rat pups not exposed to the inflammatory stimulus. Thus, this model qualifies for the concept of sensitization, which like preconditioning requires that the first exposure alone not produce damage ([@R27]). This is in contrast to some two-hit models that have the first hit produce some damage, and the second hit enhance or amplify the damage ([@R28]--[@R32]).

Why do two-hit models apply to an MDI \< 55, but not to an MDI between 55 and 69? {#S20}
---------------------------------------------------------------------------------

Our two-hit models apply to an MDI more than three standard deviations below the mean, but not to the less severe reduction of an MDI between two and three standard deviations below the mean. We are not sure why what we see prominently for an extreme outcome is not seen less extremely for a less extreme outcome. One possibility is that the set of risk factors for MDI \< 55 differs from those for MDI 55--69. Another possibility is that what we see are the consequences of a threshold effect.

SGA, inflammation, and adult diseases {#S21}
-------------------------------------

The presumed late consequences of SGA, including adult-onset diabetes, obesity, hypertension, and atherosclerotic disease are associated with inflammation ([@R33]). We did not see evidence of inflammation on the first postnatal day ([@R21]). Perhaps what we saw just a few weeks later is the earliest indication of an intense inflammatory proclivity that accounts for some of the adult diseases associated with SGA.

Epigenetic mechanisms {#S22}
---------------------

Epigenetic mechanisms, which can influence phenotypic plasticity without altering genomic DNA, have been invoked to explain a wide variety of SGA consequences, including adult diseases, ([@R33])., as well as inflammatory processes associated with neonatal brain damage ([@R34]). If processes associated with growth restriction *in utero* account for some of the brain's sensitivity to postnatal inflammation, then therapies that interfere with epigenetic processes might protect the brain ([@R34]).

Choice of potential confounders {#S23}
-------------------------------

Our search for potential confounders of the relationships among SGA, systemic inflammation, and low MDI was especially difficult because some of them might be in the causal chain leading from SGA to low MDI. For example, the majority of SGA infants were born to women who had severe preeclampsia or were delivered for fetal indications. Also, magnesium was given for seizure prophylaxis, almost exclusively to women with severe preeclampsia. Indication for delivery and duration of ventilation neither added independent information about the risk of an MDI \< 55, nor altered the odds ratios associated with SGA or any indicator of systemic inflammation. On the other hand, bacteremia contributed supplemental information about the risk of a very low MDI without altering contributions of SGA and indicators of systemic inflammation. These observations support our decision to present analyses without adjusting for these variables.

We did adjust for gestational age, because this is probably our best indicator of unidentified correlates of maturity ([@R35]). We also adjusted for sex because SGA usually predicts low MDI differently in each sex ([@R36]).

Implications {#S24}
============

If our findings are replicated, they will be an example in humans of a two-hit model of brain damage. Two implications follow from our observations. First, our findings might be simply explained as an example of an additive model of increased risk, although consideration should be given to the possibility that the consequences of SGA and systemic inflammation are more than additive. Second, effective intervention to improve outcome among SGA infants might be possible even following delivery.

Conclusions {#S25}
===========

Very preterm SGA newborns appear to be at increased risk of severely limited mental development, especially if they experienced early postnatal systemic inflammation.

METHODS {#S26}
=======

The ELGAN study was designed to identify characteristics and exposures that increase the risk of structural and functional neurologic disorders in ELGANs (the acronym for [E]{.ul}xtremely [L]{.ul}ow [G]{.ul}estational [A]{.ul}ge [N]{.ul}ewborns). During the years 2002--2004, women delivering before 28 weeks gestation at one of 14 participating institutions were asked to enroll in the study. Each institution's review board approved enrollment and consent procedures and documents. A full description of the methods is provided elsewhere ([@R37]). Here we focus on those most relevant to these analyses.

The sample for this report consists of the 805 newborns for whom we had information about protein concentrations on at least two of the three protocol days (days 1, 7, and 14), who had a developmental assessment at age 2 years post-term equivalent, and did not have a motor handicap that might interfere in assessments of cognition ([Table 1](#T1){ref-type="table"}).

After delivery, a trained research nurse interviewed each mother in her native language using a structured data collection form and following procedures defined in a manual. Shortly after the mother's discharge, the research nurse reviewed the maternal chart using a second structured data collection form. The medical record was relied on for events following admission.

Definitions of pregnancy disorders that led to preterm delivery {#S27}
---------------------------------------------------------------

The clinical circumstances that led to each maternal admission and ultimately to each preterm delivery were operationally defined using both data from the maternal interview and data abstracted from the medical record ([@R38]). Each mother/infant pair was assigned to the category that described the primary reason for the preterm delivery. Preterm labor was defined as progressive cervical dilation with regular contractions and intact membranes. The diagnosis of preterm, premature rupture of fetal membranes (pPROM) was defined as the presence of vaginal pooling with either documented nitrazine positive testing or ferning prior to regular uterine activity. Preeclampsia was defined as new onset hypertension and proteinuria of sufficient severity to warrant delivery for either a maternal or fetal indication. A diagnosis of cervical insufficiency was made when a woman presented with cervical dilation of greater than two centimeters, but no membrane rupture or perceived uterine activity. Placental abruption was defined as appreciable vaginal bleeding (either documented in the medical record or a post-partum hematocrit \<24%) and a clinical diagnosis of placental abruption in the absence of cervical change. Presentations under the category of fetal indication included severe intrauterine growth restriction based on antepartum ultrasound examination, non-reassuring fetal testing, oligohydramnious, and Doppler abnormalities of umbilical cord blood flow.

Placenta bacteriology and morphology {#S28}
------------------------------------

Delivered placentas were placed in a sterile exam basin and transported to a sampling room, where they were biopsied under sterile conditions and flash frozen. Eighty-two percent of the samples were obtained within 1 hour of delivery. At a later time, the samples were allowed to thaw at room temperature, a portion approximately 1 cm squared was removed and weighed, then diluted 1:10 with sterile phosphate buffered saline (PBS), and homogenized. Aliquots were plated on selective and non-selective media, including pre-reduced Brucella-base agar with 5% sheep blood enriched with hemin and vitamin K1, tryptic soy agar with 5% sheep blood, chocolate agar, and A-7 agar. After incubation, the various colony types were enumerated, isolated and identified by established criteria.

For histologic evaluation, representative sections were taken from all abnormal areas as well as routine sections from the umbilical cord and a membrane roll, and full thickness sections from the center and a paracentral zone of the placental disc. After training to minimize observer variability, study pathologists examined the slides for histologic characteristics listed on a standardized data form they helped create ([@R15],[@R16]). Briefly, infarcts and inter-villous fibrin, fetal stem vessel thrombosis, and decidual hemorrhage and fibrin deposition consistent with abruption were coded as present or absent. Chorionic villi were scored for syncytial knots (none, occasional, or increased).

At the chorionic plate of the disc, grade 3 acute inflammation was defined as neutrophils up to amnionic epithelium and stage 3 was defined as \>20 neutrophils/20×). Grade 3 inflammation of the external membranes, as well as of the chorion/decidua required numerous large or confluent foci of neutrophils.

Inflammation in the umbilical cord was graded from 0--5. Grade 3 required neutrophils in perivascular Wharton's jelly, grade 4 required panvasculitis and umbilical cord vasculitis extending deep into Wharton's jelly, and grade 5 required a 'Halo lesion' (ring of precipitate in Wharton's jelly encircling each vessel). Neutrophilic infiltration into fetal stem vessels in the chorionic plate required that neutrophils appeared to have migrated towards the amnionic cavity.

Newborn variables {#S29}
-----------------

The gestational age estimates were based on a hierarchy of the quality of available information. Most desirable were estimates based on the dates of embryo retrieval or intrauterine insemination or fetal ultrasound before the 14^th^ week (62%). When these were not available, reliance was placed sequentially on a fetal ultrasound at 14 or more weeks (29%), LMP without fetal ultrasound (7%), and gestational age recorded in the log of the neonatal intensive care unit (1%).

A newborn was considered to be SGA if the birth weight was in the lowest decile of the birth weight distribution in an external standard ([@R19]). This is equivalent to a birth weight more than 1.28 standard deviations below the mean in a referent population.

Documented early bacteremia required recovery of an organism from blood drawn during first postnatal week, and late bacteremia as recovery of an organism from blood drawn during the second, third, or fourth week. Presumed bacteremia was defined as culture-negative, but the clinician ordered antibiotics for more than 72 hours.

The lowest and highest arterial blood measurements of PaO~2~, PCO~2~, and pH on postnatal days 1, 2, and 3 were routinely recorded. We identified ELGANs whose blood gas measurements were in the extreme quartile for gestational age on at least two of the three days.

Information about mode of ventilation was collected for every day during the first 7 days and weekly thereafter until 28 days. ELGANs were classified into three mutually exclusive groups: those with consistently low FiO~2~ (an FiO~2~ \< 0.23 every day between postnatal days 3 and 7 and receiving FiO~2~ ≤ 0.25 on day 14), those with pulmonary deterioration (PD: an FiO~2~ \< 0.23 on any day between days 3 and 7 and receiving FiO~2~ \> 0.25 on day 14), and those with early and persistent pulmonary dysfunction (EPPD: an FiO~2~ ≥ 0.23 on all days between 3 and 7 days of life and receiving FiO~2~ \> 0.25 on day 14) 5.

24-month developmental assessment {#S30}
---------------------------------

Fully 91% of surviving children returned for a developmental assessment close to the time when s/he would be 24-months corrected age. Of these children, 77% had their exam within the range of 23.5--27.9 months. Most others were examined before 23.5 months.

Certified examiners administered and scored the Bayley Scales of Infant Development Second Edition ([@R39]). We chose as our main outcome a Mental Development Index (MDI) \< 55 because it is three standard deviations below the expected mean and therefore constitutes a severe impairment, and because the predictive ability of an MDI \< 55 is higher than that of a score below 70, which is two standard deviations below the expected mean ([@R40]). Because some MDI test items require intact motor function, we excluded all infants with significantly impaired gross motor function, defined as an inability to walk independently (a Gross Motor Function Classification System level ≥ 1), regardless of whether or not they were given a cerebral palsy diagnosis.

Blood spot collection {#S31}
---------------------

After blood was collected for clinical indications, drops were blotted on filter paper on the first postnatal day (range: 1--3 days), the 7^th^ postnatal day (range: 5--8 days), and the 14^th^ postnatal day (range: 12--15 days). Dried blood spots were stored at −70°C in sealed bags with desiccant until processed. All references below to protein concentrations refer to the 3 samples obtained on or about days 1, 7 and 14

Protein measurement {#S32}
-------------------

Details about elution of proteins from blood spots and measurement of the proteins with the Meso Scale Discovery (MSD) electrochemiluminescence system are provided elsewhere ([@R22]). Inter-assay variations are invariably less than 20%. Measurements of each protein were normalized to milligrams of total protein.

The Laboratory of Genital Tract Biology of the Department of Obstetrics, Gynecology and Reproductive Biology at Brigham and Women's Hospital, Boston measured the following 25 proteins: IL-1beta (Interleukin-1beta), IL-6 (Interleukin-6), IL-6R (interleukin-6 receptor), TNF-alpha (tumor necrosis factor-alpha), TNF-R1 (tumor necrosis factor-alpha-receptor1), TNF-R2 (tumor necrosis factor-alpha-receptor2), IL-8 (CXCL8) (interleukin-8), MCP-1 (CCL2) (monocyte chemotactic protein-1), MCP-4 (CCL13) (monocyte chemoattractant protein-4) (CCL13), MIP-1beta (CCL4) (Macrophage Inflammatory Protein-1beta) (CCL4), RANTES (CCL5) (regulated upon activation, normal T-cell expressed, and \[presumably\] secreted), I-TAC (CXCL11) (Interferon-inducible T cell Alpha-Chemoattractant), ICAM-1 (CD54) (intercellular adhesion molecule-1), ICAM-3 (CD50) (intercellular adhesion molecule-3), VCAM-1 (CD106) (vascular cell adhesion molecule-1), E-SEL (CD62E) (E-selectin) (CD62E), MMP-1 (matrix metalloproteinase-1), MMP-9 (matrix metalloproteinase-9), CRP (C-Reactive Protein), SAA (serum amyloid A), MPO (myeloperoxidase). VEGF (vascular endothelial growth factor), VEGF-R1 (vascular endothelial growth factor-receptor1), VEGF-R2 (vascular endothelial growth factor-receptor2), and IGFBP-1 (Insulin Growth Factor Binding Protein-1).

In previous analyses in this sample, protein elevations in the top quartile (for gestational age and postnatal day) on two separate days provided considerably more discriminating risk information than did elevations on just one day ([@R10]--[@R12]). Thus, our indicator of postnatal systemic inflammation is a concentration of an inflammation-related protein in the top quartile that persisted or recurred.

Data analysis {#S33}
-------------

We evaluated the following hypotheses about the risk of a low MDI, defined as either a very low MDI (*i.e.,* \<55) or a moderately low MDI (*i.e.,* between 55 and 69). First, compared to ELGANs who were neither SGA nor had recurrent/persistent post-natal systemic inflammation, those who had both characteristics were more likely to have a low MDI two years later. Second, among ELGANS who were SGA, those who had recurrent/persistent early post-natal systemic inflammation were much more likely to have a low MDI two years later. Third, among ELGANS who had recurrent/persistent early post-natal systemic inflammation, those who were SGA, were more likely to have a low MDI two years later.

Because our outcomes of interest (an MDI \< 55 and an MDI 55--69) are mutually exclusive and each is appropriately compared to the same referent group (MDI ≥ 70), we created multinomial logistic regression models. This allowed us to calculate odds ratios and 99% confidence intervals in separate models for each protein that included variables for SGA, persistent/recurrent protein concentrations in the top quartile on two days a week apart, as well as variables for gestational age (23--24, 25--26, and 27 weeks) and sex.
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###### 

Sample description

                                                                  Yes
  --------------------------------------------------------------- ------
  Enrolled                                                        1506
  Survived to 2 years                                             1200
  Bayley Scales of Infant Development assessment at age 2 years   1018
  Gross Motor Function Classification System \< 1 at 2 years      921
  Proteins measured in blood collected on 2 or 3 days             805
   Mental Development Index (MDI) ≥ 70                            629
   MDI ≥ 55, \< 70                                                85
   MDI \< 55                                                      91

###### 

The distribution of intrauterine growth restriction and postnatal systemic inflammation in categories of delivery and placenta characteristics. These are row percents.

  Characteristics of the delivery                              SGA[a](#TFN1){ref-type="table-fn"}   MDI[b](#TFN2){ref-type="table-fn"}   Protein concentration in top quartile on 2 days[c](#TFN3){ref-type="table-fn"}   N                                   
  ------------------------------------------------------------ ------------------------------------ ------------------------------------ -------------------------------------------------------------------------------- ----- ----- ----- ----- ----- ----- -----
  Antenatal corticosteroid course                              Complete                             15                                   12                                                                               11    17    17    18    15    17    517
  Partial                                                      15                                   10                                   11                                                                               15    13    15    15    19    204   
  None                                                         11                                   8                                    8                                                                                12    14    19    20    24    84    
  Pregnancy complication                                       Preterm labor                        7                                    9                                                                                10    15    14    16    16    16    366
  pPROM[d](#TFN4){ref-type="table-fn"}                         8                                    14                                   8                                                                                21    19    18    16    16    178   
  Preeclampsia                                                 55                                   17                                   12                                                                               13    17    12    9     23    102   
  Abruption                                                    7                                    5                                    11                                                                               10    9     19    10    11    88    
  Cervical insufficiency                                       3                                    15                                   10                                                                               13    21    26    21    28    39    
  Fetal indication                                             38                                   16                                   22                                                                               28    22    28    34    38    32    
  Magnesium                                                    None                                 11                                   10                                                                               13    16    14    18    16    20    254
  Tocolysis                                                    9                                    11                                   9                                                                                18    17    18    16    15    443   
  Seizure prophylaxis                                          47                                   16                                   13                                                                               11    14    14    13    24    108   
  Cesarean delivery                                            Yes                                  19                                   10                                                                               10    15    16    16    15    17    538
  No                                                           6                                    13                                   12                                                                               18    16    19    17    20    267   
  Fever[e](#TFN5){ref-type="table-fn"}                         Yes                                  5                                    14                                                                               14    16    16    20    18    27    44
  No                                                           15                                   11                                   10                                                                               16    16    17    15    17    738   
  \# of bacterial species isolated                             0                                    15                                   11                                                                               11    14    13    14    16    16    388
  1                                                            17                                   9                                    10                                                                               20    23    19    15    20    182   
  2+                                                           8                                    12                                   10                                                                               18    16    23    15    15    176   
  Membrane inflammation[f](#TFN6){ref-type="table-fn"}         Yes                                  5                                    9                                                                                11    27    20    27    23    25    148
  No                                                           16                                   11                                   11                                                                               14    15    15    14    15    584   
  Umbilical cord inflammation[g](#TFN7){ref-type="table-fn"}   Yes                                  7                                    11                                                                               11    26    19    30    23    23    125
  No                                                           16                                   10                                   11                                                                               15    16    14    13    16    591   
  Maximum number of infants                                    116                                  91                                   85                                                                               130   127   138   125   144   805   
  Maximum number of placentas                                  108                                  83                                   81                                                                               121   121   129   116   127   746   

Birth weight below the 10^th^ percentile for gestational age

Bayley Scales of Infant Development Mental Developmental Index when Gross Motor Function Classification System \< 1

Protein concentrations in the top quartile on 2 separate days a week apart

Preterm premature rupture or membranes

Within the interval from before delivery to 48 hours post delivery

Membrane inflammation is defined as inflammation of the chorionic plate (stage 3, and severity 3) or of the chorion/decidua (moderate or severe)

Inflammation of the umbilical cord grade 3 or higher, which requires neutrophils in perivascular Wharton's jelly

###### 

The distribution of intrauterine growth restriction and postnatal systemic inflammation in categories of the newborn's characteristic listed on the left. These are row percents.

  Characteristics of the infant                                SGA[a](#TFN8){ref-type="table-fn"}   MDI[b](#TFN9){ref-type="table-fn"}   Protein concentration in top quartile on 2 days[c](#TFN10){ref-type="table-fn"}   N                                   
  ------------------------------------------------------------ ------------------------------------ ------------------------------------ --------------------------------------------------------------------------------- ----- ----- ----- ----- ----- ----- -----
  Sex                                                          Male                                 10                                   15                                                                                13    15    17    15    16    18    416
  Female                                                       19                                   7                                    8                                                                                 17    14    19    15    18    389   
  Type of gestation                                            Singleton                            15                                   12                                                                                10    16    15    16    17    19    527
  Multiple                                                     13                                   9                                    12                                                                                17    16    16    17    14    278   
  Gestational age (weeks)                                      23--24                               8                                    15                                                                                10    13    17    16    15    17    149
  25--26                                                       19                                   12                                   10                                                                                17    15    17    15    19    379   
  27                                                           11                                   8                                    12                                                                                17    16    18    17    17    277   
  Birth weight (g)                                             ≤ 750                                40                                   13                                                                                13    15    19    21    20    21    284
  750--1000                                                    0                                    12                                   10                                                                                19    15    17    15    20    362   
  \> 1000                                                      0                                    6                                    9                                                                                 12    12    9     8     9     159   
  SGA                                                          Yes                                  100                                  18                                                                                11    18    27    23    22    27    116
  No                                                           0                                    10                                   10                                                                                16    14    16    14    16    689   
  Head circumference Z-score[d](#TFN11){ref-type="table-fn"}   \< −2                                77                                   17                                                                                11    23    25    38    28    25    64
  ≥ −2, \< −1                                                  30                                   15                                   14                                                                                20    19    21    19    23    186   
  ≥ −1                                                         1                                    9                                    9                                                                                 15    14    14    13    16    529   
  Maximum number of infants                                    116                                  91                                   85                                                                                130   127   138   125   144   805   
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Yudkin standard

###### 

The distribution of intrauterine growth restriction and postnatal systemic inflammation in categories of the newborn's early postnatal characteristics. These are row percents.

  Postnatal factors                                           SGA[a](#TFN12){ref-type="table-fn"}    MDI[b](#TFN13){ref-type="table-fn"}   Protein concentration in top quartile on 2 days[c](#TFN14){ref-type="table-fn"}   N                                   
  ----------------------------------------------------------- -------------------------------------- ------------------------------------- --------------------------------------------------------------------------------- ----- ----- ----- ----- ----- ----- -----
  Lowest quartile P~a~O~2~[d](#TFN15){ref-type="table-fn"}    Yes                                    18                                    14                                                                                10    17    23    23    23    25    133
  No                                                          14                                     11                                    10                                                                                16    16    17    14    17    540   
  Highest quartile P~a~O~2~[d](#TFN15){ref-type="table-fn"}   Yes                                    20                                    15                                                                                9     15    17    24    19    24    138
  No                                                          14                                     10                                    11                                                                                17    17    17    15    18    535   
  Lowest quartile PCO~2~[d](#TFN15){ref-type="table-fn"}      Yes                                    17                                    16                                                                                8     19    23    20    16    25    143
  No                                                          15                                     9                                     11                                                                                15    15    17    16    17    530   
  Highest quartile PCO~2~[d](#TFN15){ref-type="table-fn"}     Yes                                    23                                    13                                                                                16    24    21    28    24    22    154
  No                                                          13                                     11                                    8                                                                                 14    16    15    14    18    519   
  Lowest quartile pH[d](#TFN15){ref-type="table-fn"}          Yes                                    25                                    12                                                                                14    28    26    32    29    30    139
  No                                                          13                                     11                                    9                                                                                 13    15    14    12    17    534   
  Early bacteremia                                            None/suspected                         13                                    10                                                                                9     17    16    15    13    16    478
  Presumed                                                    17                                     12                                    11                                                                                14    16    19    19    17    278   
  Definite                                                    15                                     16                                    15                                                                                19    21    35    19    26    48    
  Late bacteremia                                             None/suspected                         12                                    10                                                                                9     16    14    15    14    15    481
  Presumed                                                    21                                     6                                     12                                                                                13    14    16    14    14    121   
  Culture positive                                            16                                     17                                    12                                                                                19    24    22    20    22    202   
  Mechanical/high frequency ventilation, day 7                Yes                                    19                                    14                                                                                12    18    18    21    20    21    469
  No                                                          8                                      7                                     9                                                                                 14    14    12    10    11    336   
  Mechanical/high frequency ventilation, day 14               Yes                                    19                                    13                                                                                12    16    19    20    19    22    460
  No                                                          8                                      8                                     9                                                                                 16    13    14    11    11    344   
  Mechanical/high frequency ventilation, day 21               Yes                                    20                                    13                                                                                11    17    18    21    20    21    446
  No                                                          7                                      9                                     10                                                                                16    14    16    10    12    355   
  Respiratory group classification                            EPPD[e](#TFN16){ref-type="table-fn"}   19                                    11                                                                                12    17    17    22    20    21    320
  PD[f](#TFN17){ref-type="table-fn"}                          14                                     13                                    10                                                                                16    17    15    13    15    304   
  Low FiO~2~                                                  17                                     7                                     8                                                                                 15    13    11    10    13    159   
  Maximum number of infants                                   116                                    91                                    85                                                                                130   127   138   125   144   805   
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Extreme quartile for gestational age on two of the first three postnatal days

Early and persistent pulmonary dysfunction

Pulmonary deterioration

###### 

Percent of children who had both the row and column characteristic who had an MDI \< 55 (left 2 data columns) or an MDI 55--69 (right 2 data columns). These are cell specific percents.

  Postnatal factors                               MDI \< 55[a](#TFN18){ref-type="table-fn"}   MDI 55--69[a](#TFN18){ref-type="table-fn"}             
  ----------------------------------------------- ------------------------------------------- -------------------------------------------- ---- ---- ----
  Bacteremia during the first Week                None/suspected                              19                                           8    6    10
  Presumed                                        17                                          12                                           15   10   
  Culture positive                                14                                          17                                           29   12   
  Bacteremia during weeks 2--4                    None/suspected                              12                                           9    15   9
  Presumed                                        12                                          6                                            12   13   
  Culture positive                                34                                          14                                           3    14   
  Mechanical/high frequency ventilation, day 7    Yes                                         22                                           12   12   12
  No                                              4                                           8                                            7    9    
  Mechanical/high frequency ventilation, day 14   Yes                                         20                                           12   13   12
  No                                              14                                          8                                            7    9    
  Mechanical/high frequency ventilation, day 21   Yes                                         21                                           11   10   11
  No                                              8                                           9                                            16   10   
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###### 

Odds ratio (and 99% confidence interval) of an MDI \< 55 or an MDI 55--69 vs those with and MDI ≥ 70 among children who had the characteristics listed at the top of each column. The logistic regression models are adjusted for gestational age (23--24, 25--26, 27 weeks) and sex. The sample consisted of children who had a GMFCS \< 1 and had proteins measured on 2 separate days (maximum N=805). The referent group consists of children who were not growth restricted at birth and who did not have two days of elevated concentrations of the protein listed on the left. Bold indicates odds ratios significantly \> 1.0 (p \< 0.01).

  Protein          MDI[a](#TFN20){ref-type="table-fn"} \< 55   MDI[a](#TFN20){ref-type="table-fn"} 55--69                                                                                          
  ---------------- ------------------------------------------- -------------------------------------------- --------------------- ----- ------------------- --------------------- ---------------- -----
  CRP              2.2 (0.5, 9.5)                              **3.2 (1.5, 6.7)**                           **3.8 (1.6, 8.9)**    1.0   1.6 (0.4, 7.1)      1.6 (0.7, 3.7)        1.5 (0.5, 4.2)   1.0
  SAA              **6.6 (1.6, 27)**                           **3.3 (1.7, 7.1)**                           **2.7 (1.1, 6.5)**    1.0   1.7 (0.2, 13)       **2.2 (1.01, 5.0)**   1.6 (0.6, 4.2)   1.0
  MPO              2.6 (0.5, 14)                               1.1 (0.5, 2.6)                               **2.6 (1.2, 5.9)**    1.0   0.7 (0, 9.8)        0.7 (0.3, 1.8)        1.5 (0.6, 3.7)   1.0
  IL-1β            **4.7 (1.2, 19)**                           1.7 (0.7, 3.8)                               **2.4 (1.02, 5.7)**   1.0   1.4 (0.2, 10)       1.0 (0.4, 2.6)        1.4 (0.6, 3.7)   1.0
  IL-6             **6.9 (2.3, 21)**                           1.9 (0.9, 4.4)                               1.7 (0.6, 4.6)        1.0   2.2 (0.5, 9.6)      1.1 (0.4, 2.7)        1.3 (0.5, 3.4)   1.0
  IL-6R            2.3 (0.4, 13)                               1.3 (0.6, 2.8)                               **2.7 (1.2, 6.2)**    1.0   1.8 (0.3, 10)       0.8 (0.3, 1.9)        1.3 (0.5, 3.3)   1.0
  TNF-α            **6.9 (2.0, 24)**                           2.0 (0.9, 4.6)                               2.1 (0.9, 4.3)        1.0   3.5 (0.8, 14)       1.5 (0.7, 3.5)        1.1 (0.4, 3.2)   1.0
  TNF-R1           1.2 (0.2, 8.9)                              1.1 (0.5, 2.6)                               **3.0 (1.3, 6.7)**    1.0   2.6 (0.6, 10)       0.6 (0.2, 1.7)        1.0 (0.4, 2.9)   1.0
  TNF-R2           2.5 (0.4, 14)                               1.8 (0.8, 4.0)                               **2.9 (1.3, 6.6)**    1.0   3.3 (0.7, 15)       1.9 (0.9, 4.1)        1.3 (0.5, 3.6)   1.0
  IL-8 (CXCL8)     **5.7 (1.7, 19)**                           **2.4 (1.1, 5.5)**                           2.3 (0.9, 5.6)        1.0   1.2 (0.2, 8.7)      2.1 (0.9, 4.8)        1.7 (0.7, 4.5)   1.0
  MCP-1 (CCL2)     2.8 (0.8, 10)                               1.3 (0.6, 3.1)                               **2.6 (1.1, 6.3)**    1.0   1.3 (0.2, 6.6)      1.0 (0.4, 2.5)        1.5 (0.6, 3.9)   1.0
  MCP-4 (CCL13)    1.9 (0.4, 8.2)                              0.8 (0.3, 2.0)                               **2.6 (1.1, 6.1)**    1.0   1.1 (0.2, 5.8)      0.6 (0.2, 1.5)        1.4 (0.5, 3.6)   1.0
  MIP-1β (CCL4)    **6.3 (1.4, 29)**                           2.0 (0.95, 4.3)                              **2.6 (1.1, 6.1)**    1.0   **5.3 (1.2, 24)**   1.5 (0.7, 3.2)        1.1 (0.4, 3.1)   1.0
  RANTES (CCL5)    5.6 (0.9, 36)                               1.3 (0.6, 2.8)                               **2.5 (1.1, 5.5)**    1.0   1.2 (0.1, 20)       0.7 (0.3, 1.7)        1.3 (0.5, 3.3)   1.0
  I-TAC (CXCL11)   2.3 (0.4, 13)                               1.0 (0.4, 2.4)                               **2.5 (1.1, 5.7)**    1.0   2.8 (0.7, 11)       0.4 (0.1, 1.3)        1.0 (0.3, 2.7)   1.0
  ICAM-1 (CD54)    **4.1 (1.2, 14)**                           **2.6 (1.2, 5.6)**                           **2.8 (1.1, 6.8)**    1.0   1.4 (0.3, 7.1)      1.5 (0.6, 3.4)        1.6 (0.6, 4.2)   1.0
  ICAM-3 (CD50)    1.7 (0.2, 13)                               1.6 (0.8, 3.3)                               **3.1 (1.4, 6.9)**    1.0   1.2 (0.2, 8.9)      0.6 (0.2, 1.6)        1.3 (0.5, 3.4)   1.0
  VCAM-1 (CD106)   3.3 (0.7, 16)                               1.4 (0.7, 3.1)                               **2.7 (1.2, 6.2)**    1.0   2.0 (0.4, 11)       0.8 (0.3, 1.8)        1.2 (0.5, 3.2)   1.0
  E-SEL (CD62E)    **4.4 (1.2, 17)**                           **2.2 (1.03, 4.7)**                          **2.7 (1.1, 6.5)**    1.0   3.1 (0.8, 12)       1.5 (0.7, 3.4)        1.2 (0.4, 3.4)   1.0
  MMP-1            2.7 (0.5, 16)                               0.7 (0.3, 1.8)                               **2.3 (1.04, 5.3)**   1.0   2.3 (0.4, 14)       0.6 (0.3, 1.5)        1.2 (0.4, 3.0)   1.0
  MMP-9            1.3 (0.1, 21)                               0.8 (0.3, 2.1)                               **2.6 (1.2, 5.6)**    1.0   1.2 (0.1, 19)       0.7 (0.3, 1.8)        1.4 (0.6, 3.3)   1.0
  VEGF             1.3 (0.1, 21)                               1.5 (0.7, 3.0)                               **3.0 (1.3, 6.7)**    1.0   0.8 (0.1, 12)       0.4 (0.2, 1.1)        1.3 (0.5, 3.2)   1.0
  VEGF-R1          2.1 (0.5, 8.2)                              0.6 (0.2, 1.8)                               **2.5 (1.1, 5.9)**    1.0   2.7 (0.8, 8.9)      0.8 (0.3, 2.0)        0.9 (0.3, 2.8)   1.0
  VEGF-R2          2.2 (0.4, 12)                               **2.4 (1.2, 5.0)**                           **3.4 (1.5, 7.8)**    1.0   2.2 (0.5, 9.9)      1.0 (0.4, 2.4)        1.2 (0.5, 3.4)   1.0
  IGFBP-1          **4.9 (1.7, 15)**                           2.0 (0.9, 4.8)                               2.0 (0.8, 5.3)        1.0   1.9 (0.5, 7.3)      0.9 (0.3, 2.6)        1.2 (0.4, 3.5)   1.0
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